Lucid Diagnostics Inc.
NASDAQ:LUCD
0.78 (USD) • At close December 23, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Lucid Diagnostics Inc. |
Symbool | LUCD |
Munteenheid | USD |
Prijs | 0.775 |
Beurswaarde | 45,996,356 |
Dividendpercentage | 0% |
52-weken bereik | 0.63 - 1.58 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Lishan Aklog M.D. |
Website | https://www.luciddx.com |
An error occurred while fetching data.
Over Lucid Diagnostics Inc.
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)